Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Closings
1 closing/delay reported.
Program
On WRAL at 7: Live look at educators rallying for better pay. Their push to use your tax dollars on raises at Wake County schools
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
129.12
-1.71 (-1.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sarepta Therapeutics
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Sarepta: More Drama Or Just More Noise?
April 14, 2023
Sarepta has a history at the FDA and recent reports indicate additional issues. What are the implications for accelerated approval and the long term prospects of Sarepta?
Via
Talk Markets
The Latest Analyst Ratings for Sarepta Therapeutics
April 14, 2023
Via
Benzinga
Analysts Says Stat News Article Adds Uncertainty To Sarepta's SRP-9001, But Offers Buying Opportunity Around The Weakness
April 13, 2023
Via
Benzinga
FDA Staff Had Inclination Towards Rejecting Sarepta Duchenne Gene Therapy
April 13, 2023
Reviewers at the FDA were leaning toward rejecting Sarepta Therapeutics Inc's (NASDAQ: SRPT) closely watched gene therapy for Duchenne muscular dystrophy.
Via
Benzinga
Sarepta Tumbles As Report Of Internal FDA Strife Scorches Its Gene Therapy
April 13, 2023
According to a report, some staffers wanted to reject the highly watched drug.
Via
Investor's Business Daily
Why Is Merck (MRK) Stock Up Today?
April 13, 2023
Merck (MRK) stock is on the move Thursday after the pharmaceutical company got an update from the FDA concerning Keytruda.
Via
InvestorPlace
Why Is BigBear.ai (BBAI) Stock Down 5% Today?
April 13, 2023
BigBear.ai (BBAI) stock is taking a beating on Thursday after the AI company announced the details of a public stock offering.
Via
InvestorPlace
TD Cowen Maintains Outperform Rating for Sarepta Therapeutics: Here's What You Need To Know
March 22, 2023
Via
Benzinga
The Latest Analyst Ratings for Sarepta Therapeutics
March 22, 2023
Via
Benzinga
Sarepta Therapeutics' FDA Adcomm Puts Some Risk, With Potential Approval: Analyst
March 17, 2023
Via
Benzinga
Why Is Sarepta Therapeutics (SRPT) Stock Down 12% Today?
April 13, 2023
Sarepta Therapeutics (SRPT) stock is taking a beating on Thursday following reports that the FDA was considering rejecting one of its drugs.
Via
InvestorPlace
Why Sarepta Therapeutics Stock Is Tumbling Today
April 13, 2023
Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are trading lower Thursday on the heels of a report suggesting some U.S. Food and Drug Administration staff had opposition towards Sarepta gene therapy...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 13, 2023
Via
Benzinga
2 Top Growth Stocks That Could Soar This Spring
April 06, 2023
Exciting news on the way for both of these companies could send their stock prices screaming higher.
Via
The Motley Fool
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
Sarepta Crashes On An Unexpected Roadblock For Its Gene Therapy
March 17, 2023
The decision is an about-face from what Sarepta said roughly two weeks ago.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
3 Up-and-Coming Growth Stocks to Buy Right Now
March 25, 2023
These companies are small now but could grow much larger over time.
Via
The Motley Fool
Accelerated Approval For Gene Therapies - US Health Regulator Looks To Improve Process
March 21, 2023
The FDA seeks to optimize the development of gene therapies to help get accelerated approval of therapies. The US health regulator is looking to encourage using biomarkers, such as pulse and blood...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 17, 2023
Via
Benzinga
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
March 17, 2023
A market rally is underway, but bank stocks kept tumbling.
Via
Investor's Business Daily
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Via
Benzinga
First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday
March 17, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 17, 2023
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
Via
Benzinga
Why Are Crypto Stocks COIN, MARA, RIOT, HUT, MSTR Up Today?
March 17, 2023
Crypto stocks are on the rise Friday as traders celebrate another rally for Bitcoin (BTC) as it continues recent positive movement.
Via
InvestorPlace
The 2 Stocks to Watch on a Nail-Biter Friday
March 17, 2023
Investors are preparing for a volatile day.
Via
The Motley Fool
NVDA Stock Price Prediction: Morgan Stanley Issues $304 Price Target for Nvidia Shares
March 17, 2023
Nvidia (NVDA) stock is on the move Friday as investors react to a new price target from Morgan Stanley analyst Joseph Moore.
Via
InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Down 20% Today?
March 17, 2023
Sarepta Therapeutics (SRPT) stock is sliding lower on Friday after the company announced an advisory committee meeting with the FDA.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 17, 2023
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!
Via
InvestorPlace
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.